FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3053630 · Received April 11, 2013

Report

Report Number
2124215-2013-05034
Event Type
Injury
Date Received
April 11, 2013
Date of Event
March 24, 2013
Report Date
March 27, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS EVENT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

ACCORDING TO AVAILABLE INFORMATION, THIS LEAD WAS SURGICALLY ABANDONED AND THERE WILL BE NO RETURN OF PRODUCT. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, AN AMENDED REPORT WILL BE PREPARED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS OBTAINED. A REVISION PROCEDURE WAS PERFORMED. THIS LEAD WAS SURGICALLY ABANDONED AND REPLACED. THE DEVICE WAS ALSO REPLACED TO AVOID A FURTHER PROCEDURE. THERE WAS NO ALLEGATION AGAINST THE DEVICE. POST PROCEDURE, ALL MEASUREMENTS WERE ACCEPTABLE AND SUCCESSFUL DFT TESTING WAS PERFORMED. NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS RIGHT VENTRICULAR LEAD RECEIVED FIVE INAPPROPRIATE SHOCKS AND PRESENTED TO THE EMERGENCY ROOM FOR DEVICE INTERROGATION. VALSALVA MANEUVERS ON THE POCKET REPRODUCED NOISE. IN ADDITION, HIGH OUT OF RANGE IMPEDANCE MEASUREMENTS WERE DISPLAYED. LEAD FRACTURE WAS SUSPECTED. THE PATIENT REMAINS HOSPITALIZED AND MONITORED UNTIL AN INTENDED REVISION PROCEDURE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
155878 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0128

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R